Raymond James & Associates »

Black Diamond Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $120k 24k 5.07
2020-12-31 $239k 7.5k 32.01
2020-09-30 $227k 7.5k 30.29
2020-06-30 $302k 7.2k 42.18